SLC6A3 and Parkinson disease: The results confirmed the well-known effect of TSPO genotype on [11C]PBR28 binding, whereas no evidence was found for a difference in TSPO binding between PD patients and control subjects, or for a correlation between the binding to TSPO and DAT in PD patients.